Dual therapy in IPAH and SSc-PAH. A qualitative systematic review-Reference-Cited by-同舟云学术

Dual therapy in IPAH and SSc-PAH. A qualitative systematic review

Published:2012-05 Issue:5 Volume:106 Page:730-739
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Johnson Sindhu R.,Brode Sarah K.,Mielniczuk Lisa M.,Granton John T.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference75 articles.

1. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry;D’Alonzo;Ann Intern Med,1991

2. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients;Koh;Br J Rheumatol,1996

3. Updated evidence-based treatment algorithm in pulmonary arterial hypertension;Barst;J Am Coll Cardiol,2009

4. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension;Sitbon;Circulation,2005

5. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades;Jones;Mol Pharmacol,1995

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacology in Clinical Applications: Cardiovascular Polypharmacology;Polypharmacology;2022

2. Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review;Dermatologic Therapy;2020-12-21

3. Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort;Arthritis Research & Therapy;2020-03-23

4. The effects of oral treatment for systemic sclerosis related pulmonary arterial hypertension: A systematic review and meta-analysis;Modern Rheumatology;2020-01-04

5. Systemische Sklerose – klinisches Bild, Diagnostik und Therapie;Der Hautarzt;2019-08-05